As far as I understand, no patients with Psoriasis
Post# of 72440
Posted On: 03/01/2016 10:29:02 AM
Re: rosalieone #19261
As far as I understand, no patients with Psoriasis have been treated in the clinical trials to this point. They have been aimed at securing the 505b2 pathway.
"This study is designed as an open-label, randomized, 2-period, 2-treatment, 2-sequence, single-dose intensive pharmacokinetic (PK) study conducted in healthy volunteers.
https://clinicaltrials.gov/ct2/show/NCT02101216
Also, I believe the 2a was a crossover study rather than dose optimization study but if anyone knows I am missing something please do tell.
"This study is designed as an open-label, randomized, 2-period, 2-treatment, 2-sequence, single-dose intensive pharmacokinetic (PK) study conducted in healthy volunteers.
https://clinicaltrials.gov/ct2/show/NCT02101216
Also, I believe the 2a was a crossover study rather than dose optimization study but if anyone knows I am missing something please do tell.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼